Ge-gen decoction alleviates primary dysmenorrhoea symptoms in a rat model

References

• Ahmadi, M., et al., 2022. Non-steroidal anti-inflammatory drugs: Recent advances in the use of synthetic COX-2 inhibitors. RSC Medicinal Chemistry, 13 (5), 1–9.
   Google Scholar
• Barcikowska, Z., et al., 2020. Inflammatory markers in dysmenorrhea and therapeutic options. International Journal of Environmental Research and Public Health, 17 (4), 1191.
   PubMed Web of Science ®Google Scholar
• Cephus, J.Y., et al., 2021. Estrogen receptor-alpha signaling increases allergen-induced IL-33 release and airway inflammation. Allergy, 76 (1), 255–268.
   Web of Science ®Google Scholar
• Chai, C., et al., 2020. Effect of traditional Chinese medicine formula GeGen decoction on primary dysmenorrhea: A randomized controlled trial study. Journal of Ethnopharmacology, 261, 113053.
   Web of Science ®Google Scholar
• Cheng, Y., et al., 2018. Pharmacokinetic-pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 48, 141–151.
   PubMed Web of Science ®Google Scholar
• Devost, D., Zingg, H.H. and Hébert, T.E., 2022. The MAP kinase ERK5/MAPK7 is a downstream effector of oxytocin signaling in myometrial cells. Cellular Signalling, 90, 110211.
   Web of Science ®Google Scholar
• El-Ganainy, S.O., et al., 2022. Intranasal oxytocin attenuates cognitive impairment, β-amyloid burden and tau deposition in female rats with Alzheimer’s disease: Interplay of ERK1/2/GSK3β/caspase-3. Neurochemical Research, 47 (8), 2345–2356.
   Web of Science ®Google Scholar
• Frump, A.L., et al., 2021. 17beta-estradiol and estrogen receptor alpha protect right ventricular function in pulmonary hypertension via BMPR2 and apelin. Journal of Clinical Investigation, 131 (6), e129433.
   Web of Science ®Google Scholar
• Fuentes, N. and Silveyra, P., 2019. Estrogen receptor signaling mechanisms. Advances in Protein Chemistry and Structural Biology, 116, 135–170.
   PubMed Web of Science ®Google Scholar
• Guo, W., et al., 2020. Pyruvate kinase M2 promotes prostate cancer metastasis through regulating ERK1/2-COX-2 signaling. Frontiers in Oncology, 10, 544288.
   Web of Science ®Google Scholar
• Guo, Y.J., et al., 2013. Analgesic effects of the COX-2 inhibitor parecoxib on surgical pain through suppression of spinal ERK signaling. Experimental and Therapeutic Medicine, 6 (1), 275–279.
   Web of Science ®Google Scholar
• Iacovides, S., Avidon, I. and Baker, F.C., 2015. What we know about primary dysmenorrhea today: A critical review. Human Reproduction Update, 21 (6), 762–778.
   PubMed Web of Science ®Google Scholar
• Lannigan, D.A., 2022. ERK1/2-RSK2 signaling in regulation of ERalpha-mediated responses. Endocrinology, 163 (9), bqac106
   Web of Science ®Google Scholar
• Leem, J., et al., 2019. Herbal medicine (Hyeolbuchukeo-tang or Xuefu Zhuyu decoction) for treating primary dysmenorrhea: A systematic review and meta-analysis of randomized controlled trials. Medicine, 98 (5), e14170.
   Web of Science ®Google Scholar
• Li, G., et al., 2021. Chinese herbal formula Xuefu Zhuyu for primary dysmenorrhea patients (CheruPDYS): A study protocol for a randomized placebo-controlled trial. Trials, 22 (1), 95.
   Google Scholar
• Li, N., Li, J. and Gai, P., 2022. Effects of modified Wenjing decoction combined with online publicity and education on the treatment of primary dysmenorrhea of cold coagulation and blood stasis. Journal of Healthcare Engineering, 2022, 1899356.
   PubMed Web of Science ®Google Scholar
• Lin, X., Xiang, H. and Luo, G., 2020. Targeting estrogen receptor alpha for degradation with PROTACs: A promising approach to overcome endocrine resistance. European Journal of Medicinal Chemistry, 206, 112689.
   PubMed Web of Science ®Google Scholar
• Liu, X., et al., 2022. The mechanism of ginger and its processed products in the treatment of estradiol valerate coupled with oxytocin-induced dysmenorrhea in mice via regulating the TRP ion channel-mediated ERK1/2/NF-kappaB signaling pathway. Food and Function, 13 (21), 11236–11248.
   Web of Science ®Google Scholar
• Lucas, R.M., et al., 2021. SCIMP is a spatiotemporal transmembrane scaffold for ERK1/2 to direct pro-inflammatory signaling in TLR-activated macrophages. Cell Reports, 36 (10), 109662.
   Web of Science ®Google Scholar
• Ma, C., et al., 2021. Danggui sini decoction (herbal medicine) for the treatment of primary dysmenorrhoea: A systematic review and meta-analysis. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology, 41 (7), 1001–1009.
   Google Scholar
• Marjoribanks, J., et al., 2015. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. The Cochrane Database of Systematic Reviews, 2015 (7), CD001751.
   PubMedGoogle Scholar
• Morita, W., et al., 2019. ERK1/2 drives IL-1beta-induced expression of TGF-beta1 and BMP-2 in torn tendons. Scientific Reports, 9 (1), 19005.
   Google Scholar
• Nakano, R., et al., 2020. Non-transcriptional and translational function of canonical NF-κB signaling in activating ERK1/2 in IL-1beta-induced COX-2 expression in synovial fibroblasts. Frontiers in Immunology, 11, 579266.
   PubMed Web of Science ®Google Scholar
• Nakayama, M., et al., 2022. Porphyromonas gingivalis gingipains induce cyclooxygenase-2 expression and prostaglandin E2 production via ERK1/2-activated AP-1 (c-Jun/c-Fos) and IKK/NF-κp65 cascades. Journal of Immunology (Baltimore, MD. : 1950)), 208 (5), 1146–1154.
   Web of Science ®Google Scholar
• Pluchino, N., et al., 2020. Estrogen receptor-alpha immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis. Fertility and Sterility, 113 (6), 1224–1231.e1.
   Web of Science ®Google Scholar
• Su, L., et al., 2022. Revealing the mechanism of raw and vinegar-processed Curcuma aromatica Salisb. [Zingiberaceae] regulates primary dysmenorrhea in rats via integrated metabolomics. Frontiers in Pharmacology, 13, 926291.
   Web of Science ®Google Scholar
• Sun, Q., et al., 2017. ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells. Biochemical and Biophysical Research Communications, 487 (3), 625–632.
   Web of Science ®Google Scholar
• Tang, B., et al., 2020. NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway. Journal of Inflammation (London, England), 17 (1), 22.
   Web of Science ®Google Scholar
• Tong, H., et al., 2021. Bioactive constituents and the molecular mechanism of Curcumae rhizoma in the treatment of primary dysmenorrhea based on network pharmacology and molecular docking. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 86, 153558.
   Web of Science ®Google Scholar
• Tu, F. and Hellman, K., 2021. Primary dysmenorrhea: Diagnosis and therapy. Obstetrics and Gynecology, 137 (4), 752–752.
   PubMed Web of Science ®Google Scholar
• Wong, J., et al., 2020. Salvia sclarea L. essential oil extract and its antioxidative phytochemical sclareol inhibit oxytocin-induced uterine hypercontraction dysmenorrhea model by inhibiting the Ca2+-MLCK-MLC20 signaling cascade: An ex vivo and in vivo study. Antioxidants, 9 (10), 991.
   Web of Science ®Google Scholar
• Wright, E.B. and Lannigan, D.A., 2023. ERK1/2-RSK regulation of oestrogen homeostasis. The FEBS Journal, 290 (8), 1943–1953.
   Web of Science ®Google Scholar
• Xie, Y., Qian, J. and Lu, Q., 2020. The therapeutic effect of Ge-Gen decoction on a rat model of primary dysmenorrhea: Label-free quantitative proteomics and bioinformatic analyses. BioMed Research International, 2020, 5840967–12.
   Web of Science ®Google Scholar
• Yang, L., et al., 2016. Ge-Gen Decoction attenuates oxytocin-induced uterine contraction and writhing response: Potential application in primary dysmenorrhea therapy. Chinese Journal of Natural Medicines, 14 (2), 124–132.
   PubMed Web of Science ®Google Scholar
• Yuan, L., et al., 2021. Shaofu Zhuyu decoction for primary dysmenorrhea: A protocol for systematic review and meta-analysis. Medicine, 100 (23), e26226.
   Web of Science ®Google Scholar
• Zhai, B., et al., 2010. Leukotriene B(4) BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/p42 AUF1 pathway. The Journal of Biological Chemistry, 285 (31), 23568–23580.
   Web of Science ®Google Scholar
• Zhang, Y., et al., 2021. Metabolomics study of Guizhi Fuling capsules in rats with cold coagulation dysmenorrhea. Frontiers in Pharmacology, 12, 764904.
   PubMed Web of Science ®Google Scholar
• Zhao, Q., et al., 2022. Pharmacokinetics-derived absorbed components responsible for Guizhi-Fuling capsule target PI3K/Akt-Erk to exert an anti-dysmenorrhea effect. Journal of Ethnopharmacology, 297, 115525.
   Web of Science ®Google Scholar